Cops seize 300K 'rainbow fentanyl' pills in the Bronx
Two Bronx drug pushers were busted with a stockpile of 300,000 “rainbow fentanyl” pills, with some made to look legit like pharmaceutical drugs including Xanax, officials said Thursday.
“Fentanyl pills are masquerading in many different forms, and our city is flooded with them,” Brennan said in a statement. “Any street drug, whether it looks like a legitimate pharmaceutical or like candy, may be fentanyl, and it may be lethal.” Many were pressed to make them look like oxycodone and Xanax, with preliminary testing of the stash indicating the presence of fentanyl.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Is 'rainbow fentanyl' a threat to your kids this Halloween? Experts say noThe Drug Enforcement Administration is warning that drug dealers are marketing rainbow-colored fentanyl to kids. Many drug experts say that's likely not happening.
Read more »
Is 'rainbow fentanyl' a threat to your kids this Halloween? Experts say noThe DEA says there's a new scheme by cartels and street dealers to use colored fentanyl pills to hook kids. Experts say they've seen no evidence for that — and they note that children typically lack the kind of cash that makes for good repeat customers.
Read more »
Drug-Initiated Activity Metabolomics Identifies Myristoylglycine as a Potent Endogenous Metabolite for Human Brown Fat DifferentiationWorldwide, obesity rates have doubled since the 1980s and in the USA alone, almost 40% of adults are obese, which is closely associated with a myriad of metabolic diseases such as type 2 diabetes and arteriosclerosis. Obesity is derived from an imbalance between energy intake and consumption, therefore balancing energy homeostasis is an attractive target for metabolic diseases. One therapeutic approach consists of increasing the number of brown-like adipocytes in the white adipose tissue (WAT). Whereas WAT stores excess energy, brown adipose tissue (BAT) can dissipate this energy overload in the form of heat, increasing energy expenditure and thus inhibiting metabolic diseases. To facilitate BAT production a high-throughput screening approach was developed on previously known drugs using human Simpson–Golabi–Behmel Syndrome (SGBS) preadipocytes. The screening allowed us to discover that zafirlukast, an FDA-approved small molecule drug commonly used to treat asthma, was able to differentiate adipocyte precursors and white-biased adipocytes into functional brown adipocytes. However, zafirlukast is toxic to human cells at higher dosages. Drug-Initiated Activity Metabolomics (DIAM) was used to investigate zafirlukast as a BAT inducer, and the endogenous metabolite myristoylglycine was then discovered to mimic the browning properties of zafirlukast without impacting cell viability. Myristoylglycine was found to be bio-synthesized upon zafirlukast treatment and was unique in inducing brown adipocyte differentiation, raising the possibility of using endogenous metabolites and bypassing the exogenous drugs to potentially alleviate disease, in this case, obesity and other related metabolic diseases.
Read more »
Commentary: Federal drug program serves hospitals, not patientsThe 340B program is failing that original intent, which was to benefit low-income...
Read more »
Legendary singer Etta James arrested 50 years ago today in San Antonio on drug chargesOn this date 50 years ago, Blues legend Etta James and her husband were arrested in San...
Read more »
Colombia's Petro wants to rip up old drug war playbookColombian President Gustavo Petro is attempting a dramatic shift in how his country fights drug trafficking after calling for an end to the so-called war on drugs.
Read more »